1
David L Sieverding: Hydrophilic, elastomeric, pressure-sensitive adhesive. Valleylab, Peter C Richardson, Lawrence C Akers, Gezina Holtrust, October 13, 1987: US04699146 (226 worldwide citation)

The present invention concerns a novel water-insoluble, hydrophilic, pressure-sensitive adhesive that has a number of unique characteristics including being elastomeric and ultraconformable. This adhesive includes an irradiation cross-linked synthetic organic polymer having a three-dimensional matri ...


2
John H Burton, Reginald C Bruskewitz, Michael A Mikulich, William D Saville: Female suspension procedure. American Medical Systems, Peter C Richardson, Lawrence C Akers, Gezina Holtrust, July 3, 1990: US04938760 (218 worldwide citation)

A method for suspending the urethrovesical junction in females comprises inserting sutures through a puncture or incision in the suprapubic abdominal area or through a puncture or incision in the vaginal wall, suspending the urethrovesical junction with the sutures, and anchoring the sutures with an ...


3
John H Burton, Reginald C Bruskewitz, A Michael Mikulich, William D Saville: Suturing anchoring device for use in a female suspension procedure. AMS, Peter C Richardson, Lawrence C Akers, Gezina Holtrust, November 13, 1990: US04969892 (203 worldwide citation)

An anchoring means for anchoring a suture in tissue comprises a housing, a substantially cylindrical means within said housing for receiving a suture, and an adjusting means. Another anchoring means comprises a housing, a rotating spool within said housing, a driving gear, and an adjusting means.


4
David L Sieverding: Hydrophilic, elastomeric, pressure-sensitive adhesive. Pfizer, Peter C Richardson, Lawrence C Akers, Gezina Holtrust, June 14, 1988: US04750482 (139 worldwide citation)

The present invention concerns a novel water-insoluble, hydrophilic, pressure-sensitive adhesive that has a number of unique characteristics including being elastomeric and ultraconformable. This adhesive includes an irradiation cross-linked synthetic organic polymer having a three-dimensional matri ...


5
John A Lowe III, Arthur A Nagel: Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity. Pfizer, Peter C Richardson, Lawrence C Akers, Gezina Holtrust, May 16, 1989: US04831031 (105 worldwide citation)

Arylpiperazinyl-ethyl(or butyl)-heterocyclic compounds and their pharmaceutically acceptable acid addition salts are neuroleptic agents. They are useful in the treatment of psychotic disorders.


6
John R Cardinal, William J Curatolo, Charles D Ebert: Chitosan compositions for controlled and prolonged release of macromolecules. Pfizer, Peter C Richardson, Paul H Ginsburg, Gezina Holtrust, January 23, 1990: US04895724 (104 worldwide citation)

Compositions for the controlled and prolonged release of macromolecular compounds comprise a porous matrix of chitosan having dispersed therein the macromolecular compound. Examples of macromolecules used in the composition are pharmacologically active ones such as peptide hormones, e.g. growth horm ...


7
Kenneth A Messier, Joseph D Rhum: Caprolactone polymers for suture coating. Pfizer Hospital Products Group, Charles J Knuth, Peter C Richardson, Gezina Holtrust, November 25, 1986: US04624256 (100 worldwide citation)

High molecular weight caprolactone polymers are coated on surgical sutures to improve suture properties such as smooth surface, single knot slipdown, two throw knot slipdown for repositioning, and three throw knot security.


8
Ralph P Robinson, James P Rizzi: Arylsulfonylamino hydroxamic acid derivatives. Pfizer, Peter C Richardson, Paul H Ginsburg, Gezina Holtrust, January 26, 1999: US05863949 (75 worldwide citation)

A compound of formula (I), wherein n, X, R.sup.3, R.sup.4 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, restenosis, periodontal disease, epidermolysis bullosa, scleritis and other diseases characterized ...


9
Anthony Piscopio, James P Rizzi: Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors. Pfizer, Peter C Richardson, Paul H Ginsburg, Gezina Holtrust, January 19, 1999: US05861510 (74 worldwide citation)

A compound of the formula ##STR1## wherein R.sup.1, R.sup.2 R.sup.3, R.sup.4 R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9 and Ar are as defined above, useful in the treatment of a condition seiected from the group consisting of arthritis, cancer, tisuue ulceration, restenosis, periodontal disease, ep ...


10
Thomas F McCarthy: Connector having a stop member. Pfizer, Peter C Richardson, Gezina Holtrust, B Timothy Creagan, May 7, 1996: US05514138 (64 worldwide citation)

An improved device for repairing fractured bones is provided, the device comprising a specially designed connector, which is especially useful in combination with a plate having a tab cut out, a stop, a flat portion and a bore portion and with a compression screw and a lag screw.